We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Dell
DELL
$358B
| $5.3M | 0.01% |
190,393
+6,138
| +3% | +$138K |
|
702
CrowdStrike
CRWD
$247B
| $5.3M | 0.01% |
+211,352
| New | +$4.24M |
|
703
Castle Biosciences
CSTL
$1.08B
| $5.29M | 0.01% |
140,445
+561
| +0.4% | +$19.2K |
|
704
Ford
F
$53.2B
| $5.28M | 0.01% |
868,640
-1,359,026
| -61% | -$7.53M |
|
|
ARGO
705
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $5.2M | 0.01% |
149,426
-4,098
| -3% | -$137K |
|
|
SCVX.U
706
DELISTED
SCVX Corp. Units, each consisting of one Class A ordinary share, $0.0001 par value per share, and on
SCVX.U
| $5.18M | 0.01% |
500,000
| – | – |
|
|
TWNK
707
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $5.17M | 0.01% |
423,429
+17
| +0% | +$201 |
|
708
Murphy USA
MUSA
$9.43B
| $5.17M | 0.01% |
45,888
+38,711
| +539% | +$4.24M |
|
709
DraftKings
DKNG
$12.1B
| $5.16M | 0.01% |
155,000
+30,000
| +24% | +$829K |
|
710
Hubbell
HUBB
$23.2B
| $5.14M | 0.01% |
41,026
+20,367
| +99% | +$2.48M |
|
|
DCH
711
Dauch Corp
DCH
$1.43B
| $5.06M | 0.01% |
665,249
-203,089
| -23% | -$1.17M |
|
712
Allogene Therapeutics
ALLO
$584M
| $5.04M | 0.01% |
+117,707
| New | +$4.26M |
|
|
TECX
713
Tectonic Therapeutic
TECX
$546M
| $5.01M | 0.01% |
+23,933
| New | +$4.93M |
|
714
Royal Bank of Canada
RY
$280B
| $5.01M | 0.01% |
+73,893
| New | +$4.7M |
|
715
Sunstone Hotel Investors
SHO
$2.05B
| $4.97M | 0.01% |
610,031
+396,932
| +186% | +$3.45M |
|
716
Seres Therapeutics
MCRB
$42.3M
| $4.9M | 0.01% |
51,440
| – | – |
|
717
Cooper-Standard Automotive
CPS
$407M
| $4.88M | 0.01% |
368,600
+156,527
| +74% | +$1.9M |
|
718
United Airlines
UAL
$34.5B
| $4.88M | 0.01% |
140,985
+133,060
| +1,679% | +$3.99M |
|
719
Puma Biotechnology
PBYI
$485M
| $4.86M | 0.01% |
466,266
-542,631
| -54% | -$5.62M |
|
|
NARI
720
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $4.84M | 0.01% |
+100,000
| New | +$4.78M |
|
721
Goodyear
GT
$1.49B
| $4.84M | 0.01% |
541,022
-2,936
| -0.5% | -$22.3K |
|
722
First Interstate BancSystem
FIBK
$3.52B
| $4.83M | 0.01% |
155,866
-31,128
| -17% | -$951K |
|
|
INOV
723
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $4.83M | 0.01% |
250,538
-21,235
| -8% | -$377K |
|
724
QCR Holdings
QCRH
$1.65B
| $4.82M | 0.01% |
154,577
+28,253
| +22% | +$814K |
|
725
TripAdvisor
TRIP
$1.05B
| $4.78M | 0.01% |
251,656
-251,767
| -50% | -$4.81M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.